Form 8-K · Current report
CME Group 8-K, filed Aug 11, 2026
- Filed
- CIK
- 0001156375
- Accession no.
- 0001156375-26-000051
Summary
CME Group communicated pricing changes to its clients on August 11, 2026 through Special Executive Report No. 9799, and disclosed the notice in a Form 8-K filing under Regulation FD; a copy was posted to the company's website.
Key points
- CME Group filed the disclosure under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
- The pricing changes were conveyed to clients via Special Executive Report No. 9799.
- The furnished information is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01. Regulation FD Disclosure. On August 11, 2026, CME Group Inc. communicated pricing changes to its clients via Special Executive Report No. 9799. A copy of this notice has been posted to the Company’s website. The information furnished under Item 7.01 of this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.